Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-039521
Filing Date
2025-04-25
Accepted
2025-04-25 17:20:53
Documents
7
Effectiveness Date
2025-04-25

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2513131d3_s8.htm S-8 40622
2 EXHIBIT 5.1 tm2513131d3_ex5-1.htm EX-5.1 10084
3 EXHIBIT 23.1 tm2513131d3_ex23-1.htm EX-23.1 3972
4 EXHIBIT 23.2 tm2513131d3_ex23-2.htm EX-23.2 2294
5 EX-FILING FEES tm2513131d3_ex107.htm EX-FILING FEES 15554
6 GRAPHIC tm2513131d3_ex23-1img001.jpg GRAPHIC 2290
7 GRAPHIC tm2513131d3_ex5-1img001.jpg GRAPHIC 2561
  Complete submission text file 0001104659-25-039521.txt   80701
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286781 | Film No.: 25875272
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)